
Keywords: LT; liver transplantation; CNI; calcineurin inhibitors; LD; low-dose; SD; standard-dose; HCV; hepatitis C virus; LFT; liver function test; MMF; mycophenolate mofetil; mTOR; mammalian target of rapamycin; HBV; hepatitis B virus; Biopsy; Graft rejection; Im